Thursday, July 30

Browsing: mTORC1

Survivors

Targeting CDK4/6 and mTORC1 in Translocation Renal Cell Carcinoma

By NewsCancerApril 28, 20260

Translocation renal cell carcinoma (tRCC) represents a rare and historically underserved subtype of kidney cancer, primarily characterized by gene fusions…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma

Browsing: mTORC1

Targeting CDK4/6 and mTORC1 in Translocation Renal Cell Carcinoma

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma

SETD8-mediated mono-methylation of YAP at K76 promotes K48-linked polyubiquitination and degradation to suppress colorectal cancer

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma

SETD8-mediated mono-methylation of YAP at K76 promotes K48-linked polyubiquitination and degradation to suppress colorectal cancer

Latest Post

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma

Subscribe to Updates

What's Hot

Browsing: mTORC1